hVEGF-IN-1
Cat.No:IH4170 Solarbio
CAS:1637443-98-1
Molecular Formula:C34H43N7O2
Molecular Weight:581.75
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My CartCAS:1637443-98-1
Molecular Formula:C34H43N7O2
Molecular Weight:581.75
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 1637443-98-1 |
| Name | hVEGF-IN-1 |
| Molecular Formula | C34H43N7O2 |
| Molecular Weight | 581.75 |
| Solubility | Soluble in DMSO ≥2mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| Target Point | VEGFR |
| Passage | Angiogenesis;Protein Tyrosine Kinase/RTK |
| Background | hVEGF-IN-1 is A quinazoline derivative that specifically binds to the G-rich sequence of the internal ribosome entry site A(IRES-A), thereby disrupting the G-tetrad structure; And can reduce VEGF-A protein expression, thereby impeding tumor cell migration and inhibiting tumor growth. |
| Unit | Bottle |
| Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download